Antibody finds, wipes out prostate cancer: study

December 28, 2009

US researchers have found an antibody that hunts down prostate cancer cells in mice and can destroy the killer disease even in an advanced stage, a study showed Monday.

The antibody, called F77, was found to bond more readily with cancerous prostate tissues and cells than with benign tissue and cells, and to promote the death of cancerous tissue, said the study published in the Proceedings of the National Academy of Science (PNAS).

When injected in mice, F77 bonded with tissue where was the primary cancer in almost all cases (97 percent) and in tissue cores where the cancer had metastasized around 85 percent of the time.

It recognized even androgen-independent , present when prostate cancer is incurable, the study by researchers at the University of Pennsylvania showed.

F77 "initiated direct cell death of ... and effectively prevented tumor outgrowth," it said.

But it did not target normal tissue, or tumor tissues in other parts of the body including the colon, kidney, cervix, pancreas, lung, skin or bladder, the study showed.

The antibody "shows promising potential for diagnosis and treatment of prostate cancer, especially for androgen-independent metastatic prostate cancer," which often spreads to the bones and is difficult to treat, the researchers wrote in PNAS.

Currently, the five-year survival rate for metastatic prostate cancer is just 34 percent, according to the study.

Prostate cancer is the second most common cancer among men, claiming half a million lives each year worldwide, according to the World Health Organisation (WHO).

(c) 2009 AFP

4.9 /5 (70 votes)  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

Supermegadope
Dec 28, 2009

Rank: 5 / 5 (1)
How long until they are able to start human trials?
El_Nose
Dec 29, 2009

Rank: 5 / 5 (1)
it takes 5 - 12 years ( longer depending on type of drug) to get through first 3 clinical trials. The fourth clinical trial has an indefinite period as it measures effect over lifetime of patient. You have to get through first three trials, and many times repeat the third trial a few times jus tto make sure it wasn't a fluke to get liscensing of a new drug.
croghan26
Dec 29, 2009

Rank: 5 / 5 (1)
I guess the first question is did the mice live normal lives after the injections? Were there side effects?

The drug is useless if it 'cures' the cancer but kills from some other effect.
RavenWizard
Dec 29, 2009

Rank: 4 / 5 (1)
Could this be another 'key' element' during the bio-engineering process toward an eventual vaccine? It certainly seems to be so.
psommerfeld
Dec 30, 2009

Rank: 2 / 5 (2)
Who cares? It's only relevant 5 years and $15 millions from now, if it ever makes it to human trials.
Nartoon
Dec 30, 2009

Rank: 4 / 5 (4)
It's amazing what they can cure mice of these days; cancers, fat, Alzheimer's, heart disease etc.
Paradox
Dec 30, 2009

Rank: 5 / 5 (2)
Human trials should be allowed for terminally ill patients, as they have no other hope. Any chance is better than none.
Sinister181
Dec 30, 2009

Rank: 5 / 5 (1)
Amazing. 5 - 12 years. Isn't that kind of.. ridiculous? What about the people who need it now?
Kedas
Dec 30, 2009

Rank: 3 / 5 (1)
I guess experimental projects will be possible much sooner.
Obviously you will have to sign that you take full responsibility for any results.
croghan26
Dec 30, 2009

Rank: 5 / 5 (2)
... at the time (1958) my mother was the a nurce for a doctor that refused to prescribe thalidomide. He was a responsibly individual and was afraid of just what happened.

Rushing things into usage can have horrible consequences.
DozerIAm
Dec 30, 2009

Rank: not rated yet
Here is my problem with this article, and this problem extends to many of the articles here on Physorg - they seem to love "hype based reporting".

For example, it says:
Currently, the five-year survival rate for metastatic prostate cancer is just 34 percent, according to the study.

Prostate cancer is the second most common cancer among men, claiming half a million lives each year worldwide, according to the World Health Organisation (WHO).

Note theat it gives the survival rate for METASTATIC prostate cancer and in the next sentence describes the occurence rate for ALL prostrate cancers. They follow it with the death rate from what is presumably the metastatic cancer, since regular prostrate cancer isn't deadly, but by that sentence most men are already unnecessarily worried. This is disingenuous and misleading, many men with prostrate cancer don't need treatment and most of the ones who do need it for LOCAL secondary symptoms like difficulty in urination, etc.
kshultz222_yahoo_com
Dec 30, 2009

Rank: 5 / 5 (2)
I believe any time that a "medicine" can cure another animal, humans with terminal/catastrophic patients should be given the opportunity to be given the treatments unless there are major overriding reasons why they shouldn't. As was said, any hope is better than no hope. It is cruel to do otherwise.
What we are telling patients is: "We have a cure for your terminal illness, but it MIGHT kill you. We cannot afford the risk to our . . . "
DozerIAm
Dec 30, 2009

Rank: 3.5 / 5 (2)
I believe any time that a "medicine" can cure another animal, humans with terminal/catastrophic patients should be given the opportunity to be given the treatments unless there are major overriding reasons why they shouldn't. As was said, any hope is better than no hope. It is cruel to do otherwise.
What we are telling patients is: "We have a cure for your terminal illness, but it MIGHT kill you. We cannot afford the risk to our . . . "


I agree with you. However, no contract, no matter how well explained and how clearly written and ironclad will escape the Doctor, hospital and drug manufacturer from getting sued and possibly losing a huge lawsuit. And even if they win the lawsuit, the expense in both money and community good will would be onerous. I blame this entirely on medical malpractice lawyers getting rich on settlements for cases which shouldn't have been made. Tort reform would help here, but will probably never happen.
MorituriMax
Dec 30, 2009

Rank: not rated yet
I think I have been watching stories like these for years now, but never seem to see any of these discoveries ever make it to the real world. None.

Maybe PhysOrg could do a section where they tell us about theories and trials that actually have been released for public consumption?
x646d63
Dec 30, 2009

Rank: not rated yet
If this is an antibody, it would be more helpful to know exactly how the body manufactures it, and how we can encourage its production within our own bodies.
Temple
Dec 31, 2009

Rank: not rated yet
If this is an antibody, it would be more helpful to know exactly how the body manufactures it, and how we can encourage its production within our own bodies.


Agreed. Many commenters are seemingly confusing an antibody with a chemical drug. An antibody is essentially a 'tag' that tells your own body's white blood cells: "kill this". Obviously it's important that that antibody doesn't cause your autoimmune system to start going nuts and destroying your healthy tissues, but we're not looking at the same questionable side-effects of a chemical drug or radiation treatment.
croghan26
Dec 31, 2009

Rank: 1 / 5 (1)
I believe any time that a "medicine" can cure another animal, humans with terminal/catastrophic patients should be given the opportunity to be given the treatments unless there are major overriding reasons why they shouldn't. As was said, any hope is better than no hope. It is cruel to do otherwise.
What we are telling patients is: "We have a cure for your terminal illness, but it MIGHT kill you. We cannot afford the risk to our . . . "


Methinks that using the dying to test for possible beneficial effects of drugs and treatments is morallly a shakey proposition.
Phelankell
Dec 31, 2009

Rank: 5 / 5 (2)
Methinks that using the dying to test for possible beneficial effects of drugs and treatments is morallly a shakey proposition.

Methinks that most of the dying would wish to attempt anything to extend their lives or to prevent others from suffering their pain and eventual death when it was possibly preventable.
Sinister181
Dec 31, 2009

Rank: 5 / 5 (1)
Methinks that using the dying to test for possible beneficial effects of drugs and treatments is morallly a shakey proposition.

Methinks that most of the dying would wish to attempt anything to extend their lives or to prevent others from suffering their pain and eventual death when it was possibly preventable.


Seconded.
MickeyMouse
Dec 31, 2009

Rank: 5 / 5 (1)
I can't imagine why an experimental drug is denied to the terminal patient. What does he have to lose? Furthermore, what better choice to begin safety testing but with the terminal.

I was curious why the cervix was mentioned for MALE patients ?!? Did I miss something in biology??
physpuppy
Jan 01, 2010

Rank: not rated yet
While I agree with the posters who are saying "why not give the experimental drug to terminally ill patients", there are many things to consider, even neglecting lawsuits and morality of human experimentation and the abuses that might arise -

First what if there is no curative effect and the effect of the drug is to increase suffering ten fold? (as in maybe an even more unpleasant death)

Another consideration - at the early stages of drug development, the cost for dosages are extremely high. Think of buying a car vs a "concept car". Now consider the case of the "concept car" built at a very small scale (analogy: dosage amounts for mice). Now it needs to be built to fit a person and still work properly (scaling up the chemistry to larger amounts is often not trivial)

Now who will pay for the treatment that might turn out to be ineffectual? We're not talking $1000/per dose here - likely much much more - solvents, reagents, researcher's time to produce the drug are all expensive.
GDM
Jan 02, 2010

Rank: not rated yet
As a prostate cancer victim and survivor (for now) I would welcome paying the price and absolving everyone from any legal liability (and I was a lawyer). This cancer DOES kill 50,000 men every year. A good friend of mine died within 3 months of his discovery and he was 49. I am now 62 ande accidently discovered my agressive form at 56. It was removed but came back last year. I had radiation and hormone treatment (anti-testosterone "chemical castration") and it appears to be "cured". I have a few side effects but none I can't live without. Everything otherwise is totally normal and my wife and child are happy I'm still here. Bottom line: GET the PSA TEST early and regularly. I only takes a few months for the rate of increase to explode (say, for 0.1 to over 11). If it stays low, great, otherwise, get to a Dr. immediately! Yes, most prostate cancers are slow growing and most men will die WITH it rather than FROM it, but 50,000 a year still die FROM it.
Rank 4.9 /5 (70 votes)
Relevant PhysicsForums posts
  • Exercise and weight loss
    created1 hour ago
  • Why do we have head aches? Our brains can't feel anything.
    created5 hours ago
  • "The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
    createdFeb 04, 2012
  • Oncolytic adenovirus
    createdFeb 04, 2012
  • Nutrition label stuffs and diets
    createdFeb 02, 2012
  • Lowe syndrom genetic test
    createdFeb 02, 2012
  • More from Physics Forums - Medical Sciences

More news stories

New study: Adolescents suffering from depression more likely to be bullied

A new study provides evidence that adolescents who suffer from depression are more likely to develop difficulty in peer relationships including being bullied at school.

Medicine & Health / Psychology & Psychiatry

created 11 minutes ago | popularity not rated yet | comments 0

Playing school sports affects youths' smoking

Young people's choices about using drugs and alcohol are influenced by peers—not only close friends, but also sports teammates. A new study of middle schoolers and their social networks has found that teammates' smoking ...

Medicine & Health / Health

created 13 minutes ago | popularity not rated yet | comments 0

Rothman at Jefferson research suggests abandon convention in diagnosing periprosthetic joint infection

In their search for new, better ways to diagnose periprosthetic joint infection, Rothman Institute at Jefferson researchers have discovered that measurement of C-reactive protein in the synovial fluid is extremely accurate, ...

Medicine & Health / Diseases

created 2 minutes ago | popularity not rated yet | comments 0

High-quality child care found good for children -- and their mothers

High-quality early child care isn't important just for children, but for their mothers, too. That's the conclusion of a new study by researchers at the University of Texas at Austin; the study appears in the journal Child De ...

Medicine & Health / Health

created 12 minutes ago | popularity not rated yet | comments 0

Green tea found to reduce disability in the elderly

(Medical Xpress) -- A lot of research has been done over the past several years looking into the health benefits of green tea. As a result, scientists have found that regular consumption of the beverage leads ...

Medicine & Health / Health

created 18 hours ago | popularity 4.9 / 5 (8) | comments 9 | with audio podcast report


Scared of a younger rival? Not for some male songbirds

When mature male white-crowned sparrows duel to win a mate or a nesting territory, a young bird just doesn't get much respect.

Preventing bacteria from falling in with the wrong crowd could help stop gum disease

Stripping some mouth bacteria of their access key to gangs of other pathogenic oral bacteria could help prevent gum disease and tooth loss. The study, published in the journal Microbiology suggests that t ...

New study sheds light on genetics of rice metabolism

A large-scale study analyzing metabolic compounds in rice grains conducted by researchers at the RIKEN Plant Science Center (PSC) and their collaborators has identified 131 rice metabolites and clarified the ...

Scientists develop biological computer to encrypt and decipher images

Scientists at The Scripps Research Institute in California and the Technion–Israel Institute of Technology have developed a "biological computer" made entirely from biomolecules that is capable of deciphering ...

Mars-bound NASA rover carries coin for camera checkup

(PhysOrg.com) -- The camera at the end of the robotic arm on NASA's Mars rover Curiosity has its own calibration target, a smartphone-size plaque that looks like an eye chart supplemented with color chips ...

Entire genome of extinct human decoded from fossil

(PhysOrg.com) -- In 2010, Svante Pääbo and his colleagues presented a draft version of the genome from a small fragment of a human finger bone discovered in Denisova Cave in southern Siberia. The ...